First Therapy Approved for Dangerous Metabolic Disorder
(MedPage Today) -- The FDA on Wednesday granted accelerated approval to pariglasgene brecaparvovec (Genglycos) as the first treatment for glycogen storage disease type Ia (GSDIa), an inherited metabolic disorder that requires frequent consumption...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.